The high-priority National Security Space Launch Phase 3 missions include six launches in FY2027, nine in FY2028 and 10 in ...
AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...
Mossad signals Phase 3 strategy to destabilise Iran from within as blockade risks economic collapse, rising unrest and ...
Intellia Therapeutics details progress in Phase 3 trials for NTLA-2002 and nex-z, anticipating key regulatory submissions by 2026. Intellia Therapeutics has announced the initiation of the global ...
Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
Alkermes has reported another phase 2 win for its narcolepsy drug candidate, succeeding where Takeda failed to maintain its hopes of being first to market in the indication. The trial randomized 93 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results